No. CQ rarely surfaces, usually once a year for the AGM or maybe twice a year, like last year. The way it was explained to me is that CQ is needed, because he is an actual Dermatologist Dr with actual White Coat credentials. CQ picks up his 40K a year (that may soon increase to 75K) and any Performance Bonuses like the 5 million shares last year and all the many other shares throughout the last 15 years, for basically being a Dermatologist. I tested this theory 4 years ago by attempting to book an appointment with CQ for a small patch of psoriasis (of which he specialises in) I had on one of my legs. While I was in Perth, prior to the AGM, I tried to book an appointment. Evidently I left my run too late as you need to book at least 6 months in advance. I still went to check out the practice that is Ardross Perth and booked an appointment with one of his colleagues. They told he was constantly booked out as a Specialist, which might explain why he doesn't spend much time at OBJ. CQ has a decent reputation as a Dermatologist, but many on here are unsure as to his complete purpose relating to OBJ or whether it is partly a gentleman's favour from the often talked about 'boys club'. The last we heard from CQ was back in November 2017, where CQ conducted a Nicotinamide Penetration Study, supposedly for a new silcone brush applicator to deliver Nicotinamide. Throw in a reference for 'Nicotinamide has been suggested as a potent anti-skin cancer treatment' and release it 3 days prior to the 2017 AGM and perhaps it may help get AGM Resolutions across the line. But it all went pear-shaped as you will remember. Nicotinamide (NAM), also known as niacinamide, is a form of vitamin B3 found in food and used as a dietary supplement and medication' and most on here considered this a redundant exercise as we already had delivery data and analytics from previous successful 'Penetration Studies' conducted by P&G. So we already knew it was a successful deliverable molecule and by how much. Another nifty magician's trick if you can pull it off. We haven't heard a peep since from either CQ or the ramifications of that little trial that warranted it's own ASX announcement and touted 'OBJ will now use these results to attract an industry partner active in this market':
One thing I respect about Steve and Tony is at least they are putting their money where their mouths are and have bought shares in the last 12 months; incidentally more shares than Jeff, Glyn and Chris have bought in the last 15 years. Just not convinced they have earned a pay-rise yet.
OBJ Price at posting:
2.2¢ Sentiment: Hold Disclosure: Held
(20min delay)